Search

You searched for "Neuro-Ophthalmology"

2795 results found
JAAPOS journal cover image.

Does delayed strabismus surgery have an association with psychiatric diagnoses in children?

4 December 2025 | | EYE - Strabismus, EYE - Paediatrics
The authors present a retrospective cohort study with the aim of assessing the association between strabismus surgery in early childhood and psychiatric diagnosis incidence. An international healthcare records platform was utilised to access electronic medical records from 92 healthcare organisation....

MacuMira and Keeler announce strategic partnership to expand dry AMD therapy

11 December 2025 | Contracts & Distributors, Research & Development
Keeler, a global leader in ophthalmic innovation with more than a century of heritage, and MacuMira Medical Devices Inc, a pioneering Canadian company, has announced a strategic partnership. Under the agreement, Keeler will manufacture the MacuMira device and lead its...

BBC News Highlights New Approach to Treating Ocular Hypotony

21 January 2026 | Research & Development, Company Profiles
Ocular hypotony has been in the spotlight following recent BBC News coverage highlighting how new clinical research is delivering meaningful benefits for patients affected by this sight threatening condition. The feature draws attention to a newly published study from the...

Marsha de Cordova MP presented with an Honorary Fellowship of The College of Optometrists

6 February 2026 | optometry
This week, The College of Optometrists formally presented Marsha de Cordova MP with an Honorary Fellowship at the College’s headquarters in London. Marsha de Cordova is the Labour MP for Battersea, a former Lambeth Councillor and a longstanding champion of...

Everyday diabetes medicine could treat common cause of blindness

16 February 2026 | research, pharma
Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries. People with diabetes over the age of 55 years taking metformin were...

Sheraz Daya awarded prestigious IIRSI gold medal for contribution to ophthalmology

20 March 2026 | Leadership, Professional development
Centre for Sight, the UK’s leading and most trusted centre of excellence for advanced eye care, innovation and life-changing results, is proud to announce that its Founder and Medical Director, Sheraz Daya, has been awarded the prestigious IIRSI Gold Medal...

Surgitrac Offers Free 2 Week Trial on Ophthalmic Operating Tables

30 March 2026 | Company Profiles, Research & Development
Surgitrac Instruments is proud to offer a free 2-week trial of its advanced ophthalmic operating solutions. This exclusive opportunity is ideal for NHS and private clinics, ophthalmic surgeons, theatre teams, and procurement professionals looking to enhance surgical performance and patient...

Introducing the Surgitrac Information Hub: A New Resource for Ophthalmic Professionals

8 June 2026 | Company Profiles, Research & Development
Finding reliable, practical information in ophthalmology should not feel difficult. That is why Surgitrac has launched its brand-new Information Hub, a dedicated online resource designed to support surgeons, theatre teams, nurses and procurement professionals with trusted educational content and essential...

Supplements

Welcome to our supplements, please select a name and the issue will appear.

Unlocking the power of simulation: a next generation solution to training ophthalmic professionals

30 November 2020
With experts predicting that global blindness will triple by 2050, and the number of people requiring eyecare already outpacing the number of trained ophthalmologists, eyecare training has never been more vital. Traditional in-person ophthalmic training has been curtailed by the...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

29 March 2023 | glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Oriel celebrates breaking ground milestone

17 July 2023 | Oriel, London
A special breaking ground celebration was held on 11 July to mark the start of construction to build Oriel, a new eyecare, research and education centre in Camden.